Brief: XtalPi Announces Strategic Partnership With Potential Deal Value Over $400 Mln
June 9 (Reuters) - XtalPi Holdings Ltd2228.HK : * ANNOUNCES STRATEGIC PARTNERSHIP WITH DEAL VALUE OVER US$400 MILLION * STRATEGIC PARTNERSHIP WITH A LEADING BIOPHARMA COMPANY TO DEVELOP ORAL SMALL MOLECULE THERAPEUTICS FOR A GPCR TARGET * PARTNER TO PROVIDE UPFRONT PAYMENT AND FUND EARLY R&D; XTALPI ELIGIBLE FOR MILESTONES AND ROYALTIES Further company coverage:2228.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on XtalPi Holdings
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Hong Kong-listed XtalPi climbs as chairman buys shares
Brief: XtalPi Says Chairman Purchases 3.8 MLN Shares From Oct 7 To Oct 15
Brief: XtalPi Reports Chairman Wen Shuhao Purchases 1.3 Million Shares on Oct 7
XtalPi hits near 4-month high as chairman plans to buy shares